Pharming Group (OTCMKTS:PHGUF) Reaches New 52-Week High – Here’s What Happened

Pharming Group NV (OTCMKTS:PHGUF)’s share price hit a new 52-week high during trading on Thursday . The company traded as high as $1.53 and last traded at $1.53, with a volume of 2400 shares. The stock had previously closed at $1.50.

Pharming Group Stock Performance

The company has a debt-to-equity ratio of 0.50, a quick ratio of 2.07 and a current ratio of 2.79. The firm’s 50 day moving average is $1.47 and its two-hundred day moving average is $1.22.

Pharming Group (OTCMKTS:PHGUF) last issued its quarterly earnings results on Thursday, November 6th. The biotechnology company reported $0.01 EPS for the quarter. Pharming Group had a negative net margin of 2.19% and a negative return on equity of 3.31%. The firm had revenue of $97.30 million for the quarter, compared to analysts’ expectations of $80.18 million.

Pharming Group Company Profile

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.